A passive system using rifampin to create an infection-resistant vascular prosthesis

Area of Science:

• Biomaterials Science
• Infectious Disease Research
• Vascular Surgery

Background:

• Vascular prosthesis infection is a serious complication following vascular surgery.
• Developing infection-resistant vascular graft materials is crucial for patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of rifampin-impregnated Dacron vascular prostheses in preventing infection.
• To determine the duration of antibiotic release and inhibitory activity from preclotted grafts.

Main Methods:

• Dacron vascular prostheses were preclotted with blood containing rifampin in a canine model.
• Graft segments were cultured with Staphylococcus aureus at various time points (0, 15, 60 minutes, 24 hours).
• Antibiotic elution and inhibitory activity were assessed by measuring zones of inhibition.

Main Results:

• Rifampin demonstrated sustained inhibitory activity against Staphylococcus aureus for up to 24 hours.
• Antibiotic dialysis from the porous Dacron graft was significantly slow, maintaining 91% of initial inhibition at 24 hours.
• Other tested antibiotics showed no significant inhibition at 24 hours.

Conclusions:

• Pre-soaking Dacron vascular prostheses with rifampin-containing blood offers a simple, passive method for infection resistance.
• This technique provides prolonged, localized antibiotic presence, potentially reducing prosthesis infection rates.